Bristol-Myers Squibb Company (BMY) Stock Forecast & Price Target
Bristol-Myers Squibb Company · NYSE
$64.63-2.19 (-3.28%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 17 firms covering Bristol-Myers Squibb Company, 9 rate it Buy or better, 7 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets range widely, $37.00 to $75.00 (about 2.0x), a sign of real disagreement on valuation. The average target of $65.06 sits 1% above the current $64.63. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 6 to 9 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.59 next quarter toward $6.56 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS17 ratings
Moderate Buy
Strong Buy00%
Buy953%
Hold741%
Sell16%
Strong Sell00%
Based on 17 analysts giving stock ratings to Bristol-Myers Squibb Company.
As of Sep, 9 of 17 firms rate BMY a Buy (7 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
BMY EPS & revenue forecast
EPS · NEXT QUARTER
$1.59
Range $1.28 – $1.71 · 20 analysts · +26% YoY
Next period, 20 analysts expect Bristol-Myers Squibb Company to earn $1.59 a share (range $1.28 – $1.71), versus $1.26 a year earlier. Full-year consensus is $6.95, growing to $6.56 the year after.
REVENUE · NEXT QUARTER
$12.7B
Range $12.1B – $13.0B · 20 analysts · +2% YoY
Revenue is expected to reach $12.7B (range $12.1B – $13.0B), +1.6% year-over-year. Full-year consensus is $49.8B, rising to $48.1B next year.
Top analysts covering Bristol-Myers Squibb Company
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BMY.
#1
David Amsellem
Piper Sandler · Rank #107
Buy
$75.00+16.1% to target
Overall win rate
50%
+ Follow
#2
Jason Gerberry
B of A Securities · Rank #125
Buy
$71.00+9.9% to target
Overall win rate
46%
+ Follow
#3
Mohit Bansal
Wells Fargo
Hold
$65.00+0.6% to target
Coverage
—
+ Follow
#4
Carter Gould
Cantor Fitzgerald
Hold
$59.00-8.7% to target
Coverage
—
+ Follow
#5
Seamus Fernandez
Guggenheim
Buy
$75.00+16.1% to target
Coverage
—
+ Follow
BMY stock forecast FAQ
What is BMY's average 12-month price target?+
The 17 analysts with a live target average $65.06 for Bristol-Myers Squibb Company over the next 12 months, ranging from a $75.00 high to a $37.00 low.
Is BMY stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 17 analyst ratings, 9 are Buy or Strong Buy, 7 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for BMY?+
The Street-high target is $75.00 (Argus Research), and the Street-low is $37.00 (Morgan Stanley). The average of all 17 active targets is $65.06.
How many Wall Street analysts cover BMY?+
17 analysts have an active rating on Bristol-Myers Squibb Company, and 17 firms carry a live 12-month price target.
Who is the most accurate analyst covering BMY?+
Among analysts who currently cover BMY, David Amsellem of Piper Sandler has the strongest overall Quantellect track record (Rank #107). Their current call is Buy with a $75.00 target.
What is Bristol-Myers Squibb Company's projected EPS for next quarter?+
The consensus estimate is $1.59 per share (range $1.28 – $1.71) across 20 analysts. Full-year EPS is projected at $6.95, rising to $6.56 the following year.
How much revenue is Bristol-Myers Squibb Company expected to report next quarter?+
Consensus revenue is $12.7B (range $12.1B – $13.0B). Full-year revenue is projected at $49.8B, growing to $48.1B next year.
Have analysts been upgrading or downgrading BMY lately?+
As of Sep, 9 of 17 firms rate BMY a Buy (7 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BMY calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
